We reasoned that individuals with PHS or nonsyndromic HH without an initial genetic diagnosis may harbor mosaic variants within GLI3 below the level of detection of standard clinical genetic testing or not called by research variant calling pipelines that are designed to screen germline variants. The gene discussed is GLI3; the disease is Pallister-Hall syndrome.